肥胖型肌少症－文獻回顧

Sarcopenic Obesity- Literature Review

10.6386/CGN.202112_32(4).0003

陳杰(Chieh Chen)

肌少症 ； 衰弱症 ； 跌倒 ； 肌少型肥胖症 ； 預後 ； sarcopenia ； frailty ； fall ； sarcopenic obesity ； outcome

長庚護理

32卷4期（2021 / 12 / 01）

28 - 38

繁體中文

已有許多病生理機轉被提出與「老年衰弱症」有關，其中「肌少症」被認為與衰弱有高度的相關性，而肥胖型肌少症也屬於一種肌少症；正常老化下肌肉質量會隨著年齡增長而下降；肌肉質量與強度的衰退，容易影響步態和平衡，進而容易跌倒，造成行動能力下降，促使衰弱速度加速；又，許多急、慢性疾病及老化的相關狀況，也會間接或直接誘發衰弱的產生；衰弱又會更進一步使疾病、肌肉質量及相關情況惡化，導致衰弱老人進入每況愈下的惡性循環。

Many pathophysiological mechanisms have been proposed to be related to ＂frailty＂, among which ＂sarcopenia＂ is considered to be highly correlated with frailty. Sarcopenic obesity is also the type of sarcopenia that is more likely to be overlooked. Under normal aging, muscle mass will decline with age. The decline of muscle mass and strength can easily affect gait and balance, leading to frequent falls and affecting mobility and accelerating frailty. In addition, many acute or chronic diseases related to aging can indirectly or directly induce the frailty. Frailty will further worsen the disease, muscle mass, and related conditions, causing the frail elder to enter a vicious circle of deteriorating.

1. (2018).Fragility Fracture Nursing.Springer.
2. Cesari, M,Landi, F,Calvani, R(2017).Rationale for a preliminary operational definition of physical frailty and sarcopenia in the SPRINTT trial.Aging Clinical and Experimental Research,29(1),81-88.
3. Chen, Liang-Kung,Woo, Jean,Assantachai, Prasert,Auyeung, Tung-Wai,Chou, Ming-Yueh,Iijima, Katsuya,Jang, Hak Chul,Kang, Lin,Kim, Miji,Kim, Sunyoung,Kojima, Taro,Kuzuya, Masafumi,Lee, Jenny S W,Lee, Sang Yoon,Lee, Wei-Ju,Lee, Yunhwan,Liang, Chih-Kuang,Lim, Jae-Young,Lim, Wee Shiong,Arai, Hidenori(2020).Prasert Assantachai Asian Working Group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment.Journal of the American Medical Directors Association,21(3),300-307.
4. Chen, LK,Liu, LK,Woo, J.,Assantachai, P.,Auyeung, T. W.,Bahyah, K. S.,Arai, H.(2014).Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia.Journal of the American Medical Directors Association,15(2),95-101.
5. Chen, LK,Woo, J,Assantachai, P(2020).Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment.Journal of the American Medical Directors Association,21(3),300-307.
6. Chuang, S. Y.,Hsu, Y. Y.,Chen, R. C.,Liu, W. L.,Pan, W. H.(2016).Abdominal obesity and low skeletal muscle mass jointly predicted total mortality and cardiovascular mortality in elderly population.Journals of Gerontology. Series A, Biological Sciences and Medical Sciences,71(8),1049-1055.
7. Cruz-Jentoft, A. J.,Sayer, A. A.(2019).Sarcopenia.The Lancet,393(10191),2636-2646.
8. Cruz-Jentoft, AJ,Baeyens, JP,Bauer, JM(2010).Sarcopenia: European consensus on definition and diagnosis. Report of the European Working Group on Sarcopenia in Older PeopleA. J. Cruz-Gentoft et al.Age and ageing,39(4),412-423.
9. Cruz-Jentoft, AJ,Bahat, G,Bauer, JM(2019).Sarcopenia: revised European consensus on definition and diagnosis.Age and ageing,48(1),16-31.
10. Cruz-Jentoft, AJ,Kiesswetter, E,Drey, M,Sieber, CC.(2017).Nutrition, frailty, and sarcopenia.Aging clinical and experimental research,29(1),43-48.
11. Cruz-Jentoft, AJ,Landi, F,Topinkova, E,Michel, JP(2010).Understanding sarcopenia as a geriatric syndrome.Curr Opin Clin Nutr Metab Care,13,1e7.
12. Dawson-Hughes, B,Bischoff-Ferrari, H.(2016).Considerations concerning the definition of sarcopenia.Osteoporosis international,27(11),3139-3144.
13. Dupuy, C,Lauwers Cances, V,Guyonnet, S(2015).Searching for a relevant definition of sarcopenia: results from the cross sectional EPIDOS study.Journal of Cachexia Sarcopenia and Muscle,6(2),144-154.
14. Hong, Ho Cheol(2014).Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.Hepatology,59(5),1772-1778.
15. Kim, Jinhee(2016).Association of serum vitamin D with osteosarcopenic obesity: Korea National Health and Nutrition Examination Survey 2008–2010.Journal of Cachexia, Sarcopenia and Muscle
16. Levine, Morgan E.,Eileen, M.(2012).Crimmins : The impact of insulin resistance and inflammation on the association between sarcopenic obesity and physical functioning.Obesity,20(10),2101-6.
17. Marzetti, E,Calvani, R,Tosato, M(2017).Sarcopenia: an overview.Aging clinical and experimental research,29(1),11-7.
18. McGrath, R,Hackney, KJ,Ratamess, NA,Vincent, BM,Clark, BC,Kraemer, WJ(2020).Absolute and body mass index normalized handgrip strength percentiles by gender, ethnicity, and hand dominance in Americans.Advances in geriatric medicine and research,2(1)
19. Migliavacca, E.,Tay, S. K.,Patel, H. P.,Sonntag, T.,Civiletto, G.,McFarlane, C.,Feige, J. N.(2019).Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities.Nature communications,10(1),1-14.
20. Morley, JE(2008).Diabetes, sarcopenia, and frailty.Clinics in geriatric medicine,24(3),455-469.
21. Peterson, SJ,Mozer, M(2017).Differentiating sarcopenia and cachexia among patients with cancer.Nutrition in Clinical Practice,32(1),30-39.
22. Scott, D,Sanders, KM,Aitken, D,Hayes, A,Ebeling, PR,Jones, G(2014).Sarcopenic obesity and dynapenic obesity: 5 year associations with falls risk in middle aged and older adults.Obesity,22(6),1568-1574.
23. Tanimoto, Y,Watanabe, M,Sun, W(2014).Sarcopenia and falls in community-dwelling elderly subjects in Japan: Defining sarcopenia according to criteria of the European Working Group on Sarcopenia in Older People.Archives of gerontology and geriatrics,59(2),295-299.
24. Visser, M.(2009).Towards a definition of sarcopenia—results from epidemiologic studies.The Journal of Nutrition, Health and Aging,13(8),713-716.
25. Von Haehling, S,Morley, JE,Anker, SD(2010).An overview of sarcopenia: facts and numbers on prevalence and clinical impact.J Cachexia Sarcopenia Muscle,1,129-133.